Download Citation
Article Source:
Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells
Choupani E,
Madjd Z,
Saraygord-Afshari N,
Kiani J,
Hosseini A
(2022)
Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells.
PLOS ONE 17(12): e0279522.
https://doi.org/10.1371/journal.pone.0279522